反応式
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18][CH3:19])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=O)[C:6]=2[CH:22]=1.COC1C=CC(P2(=S)SP(=S)(C3C=CC(OC)=CC=3)[S:32]2)=CC=1>C1(C)C=CC=CC=1>[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18][CH3:19])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[S:32])[C:6]=2[CH:22]=1参加物
実験手順
10.7 g (35.3 mmol) of ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate and 7.13 g (17.6 mmol) of 2,4-bis(p-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulphide in 100 ml of toluene are heated to boiling under reflux for 22 hours. The mixture is subsequently concentrated in vacuo until crystallisation begins and is then left to stand in an ice-bath for 1 hour. The crystallised-out material is filtered off under suction and washed with a small amount of toluene. The mixture is separated on silica gel with ethyl acetate/chloroform (1:9). After recrystallisation from ethyl acetate, there is obtained pure ethyl 8-fluoro-5,6-dihydro-5-methyl-6-thioxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 157°-159° C.
後処理
- temperatureunder reflux for 22 hours
- concentrationThe mixture is subsequently concentrated in vacuo until crystallisation
- waitis then left
- filtrationThe crystallised-out material is filtered off under suction
- washwashed with a small amount of toluene
- customThe mixture is separated on silica gel with ethyl acetate/chloroform (1:9)
- customAfter recrystallisation from ethyl acetate
出典と根拠
- ORDレコード
- ord-b84ca8c0e2f343cc8dfa43723674dc70
- 出典データセット
- uspto-grants-1982_08
- 特許番号
- US04346030
関連ノート
読み込み中…